Post-pandemic blues of predatory pharma
Huge stockpiles of COVID-19 vaccines and treatments, along with a steep drop in revenues, tell a sorry tale of Big Pharma’s greed
The squalid history of medical patents
Bringing medicines into the global intellectual property regime was a triumph of corporate skulduggery led by Pfizer
COVID-19: How is expiration date of vaccines determined?
Expired vaccines are not particularly unsafe or dangerous, say experts
Pfizer wants to sell vaccines in India at no profit
The Pfizer vaccine is yet to be registered in India although it had applied months ago
How Rwanda reached first global COVID-19 vaccination target
Rwanda defined a vaccination plan prior to getting the vaccines
Global COVID-19 cases set to triple with over 3 billion omicron infections in coming 2-3 months: IHME
Australia and New Zealand may experience their worst outbreaks of this pandemic
New Delta+ variant found in India can escape antibodies
Mutations in the Delta+ variant can render vaccines and treatments ineffective
Lateral Thoughts: Waiting for the vaccine?
Vaccination programmes cannot be dealt with outside the purview of public health
Pfizer withdraws application for Emergency Use Authorisation in India
The company will resubmit application after getting more data
Omicron may already be in most countries, WHO warns
People dismissing omicron infection as mild may fuel spread, says WHO
Experts suggest updating vaccines for new variants. How does it work & what are the challenges?
It is easier to update certain vaccine platforms than others, say experts
Strong medicine for weak drug patents
Revocation of Pfizer, Roche patents for lacking inventive step signals healthy trend
Make unethical drug trials a punishable offence, say experts
Current laws do not fix penalty if such practices are found
Drug trials: Irked NHRC issues notices to Centre and Andhra Pradesh government
Says respond else face action
US piles on the pressure
Patent law, domestic content rules in solar and ICT policy come under attack